Drugmakers are racing to develop a vaccine and treatment for the epidemic, which has which killed 1,770 people and infected over 70,500 people across China.
Plasma from patients who have recovered from a spell of pneumonia triggered by COVID-19 contains antibodies that can help reduce the virus load in critically ill patients, an official from China´s National Health Commission told a press briefing Monday. Eleven patients at a hospital in Wuhan — the epicentre of the disease — received plasma infusions last week, said Sun Yanrong, of the Biological Center at the Ministry of Science and Technology.
I very like this blog. Everything is cleared.